Pro: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery

被引：13
作者：
Body, Simon C.
Mazer, C. David
机构：
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, Boston, MA 02115 USA
[2] Univ Toronto, St Michaels Hosp, Dept Anesthesia, Toronto, ON M5B 1W8, Canada
来源：
ANESTHESIA AND ANALGESIA | 2006年 / 103卷 / 06期
关键词：
D O I：
10.1213/01.ane.0000246810.88697.15
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：1354 / 1359
页数：6
相关论文
共 46 条
[1]   Analyses of coronary graft patency after aprotinin use: Results from the international multicenter aprotinin graft patency experience (IMAGE) trial [J].
Alderman, EL ;
Levy, JH ;
Rich, JB ;
Nili, M ;
Vidne, B ;
Schaff, H ;
Uretzky, G ;
Pettersson, G ;
Thiis, JJ ;
Hantler, CB ;
Chaitman, B ;
Nadel, A .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 116 (05) :716-729
[2]   Total arterial revascularization is safe: Multicenter ten-year analysis of 71,470 coronary procedures [J].
Baskett, RJF ;
Cafferty, FH ;
Powell, SJ ;
Kinsman, R ;
Keogh, BE ;
Nashef, SAM .
ANNALS OF THORACIC SURGERY, 2006, 81 (04) :1243-1248
[3]   APROTININ THERAPY IN CARDIAC OPERATIONS - A REPORT ON USE IN 41 CARDIAC CENTERS IN THE UNITED-KINGDOM [J].
BIDSTRUP, BP ;
HARRISON, J ;
ROYSTON, D ;
TAYLOR, KM ;
TREASURE, T .
ANNALS OF THORACIC SURGERY, 1993, 55 (04) :971-976
[4]  
Bohrer H, 1990, J Cardiothorac Anesth, V4, P222, DOI 10.1016/0888-6296(90)90241-7
[5]   Pharmacokinetics of ε-aminocaproic acid in patients undergoing aortocoronary bypass surgery [J].
Butterworth, J ;
James, RL ;
Lin, YG ;
Prielipp, RC ;
Hudspeth, AS .
ANESTHESIOLOGY, 1999, 90 (06) :1624-1635
[6]   Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials [J].
Carless P.A. ;
Moxey A.J. ;
Stokes B.J. ;
Henry D.A. .
BMC Cardiovascular Disorders, 5 (1)
[7]   APROTININ THERAPY FOR REOPERATIVE MYOCARDIAL REVASCULARIZATION - A PLACEBO-CONTROLLED STUDY [J].
COSGROVE, DM ;
HERIC, B ;
LYTLE, BW ;
TAYLOR, PC ;
NOVOA, R ;
GOLDING, LAR ;
STEWART, RW ;
MCCARTHY, PM ;
LOOP, FD .
ANNALS OF THORACIC SURGERY, 1992, 54 (06) :1031-1038
[8]   Aprotinin in primary valve replacement end reconstruction: A multicenter, double-blind, placebo-controlled trial [J].
DAmbra, MN ;
Akins, CW ;
Blackstone, EH ;
Bonney, SL ;
Cohn, LH ;
Cosgrove, DM ;
Levy, JH ;
Lynch, KE ;
Maddi, R .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 112 (04) :1081-1089
[9]   Clinical inhibition of the seven-transmembrane thrombin receptor (PAR1) by intravenous aprotinin during cardiothoracic surgery [J].
Day, JRS ;
Punjabi, PP ;
Randi, AM ;
Haskard, DO ;
Landis, RC ;
Taylor, KM .
CIRCULATION, 2004, 110 (17) :2597-2600
[10]   Anaphylactic reactions to aprotinin reexposure in cardiac surgery -: Relation to antiaprotinin immunoglobulin G and E antibodies [J].
Dietrich, W ;
Späth, P ;
Zühlsdorf, M ;
Dalichau, H ;
Kirchhoff, PG ;
Kuppe, H ;
Preiss, DU ;
Mayer, G .
ANESTHESIOLOGY, 2001, 95 (01) :64-71
12345